Why Asian Brands Struggle to Launch in the U.S.: A 2026 Diagnostic Guide

Most Korean and Japanese consumer brands that struggle in the United States are not struggling because their products are bad. They are struggling because every assumption they brought from home, about how shoppers discover products, what builds trust, which claims are allowed, and how supply chains work, turns out to be wrong in the U.S. market. This article names the six barriers that account for the majority of failed or stalled U.S. launches by Asian brands, and for each one, explains specifically what to do instead.

1. The regulatory gate: MoCRA, FSMA/FSVP, and the sesame allergen

The most common operational mistake Asian brands make is treating U.S. regulatory compliance as something to sort out after the first shipment lands. In 2026, that sequence guarantees delays, listing suppressions, or FDA notices that are expensive to unwind.

Cosmetics: MoCRA and the responsible person requirement

The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) is the first major overhaul of U.S. cosmetics law since 1938, and enforcement has been in effect since July 2024. For any Korean or Japanese cosmetics brand selling in the U.S., the core obligations are: register every manufacturing facility with the FDA, list each marketed product and update that listing annually, maintain written safety substantiation for each product, designate a U.S.-based responsible person whose name and address appear on the label, and report serious adverse events within 15 business days. The FDA can suspend a facility registration if a product from that facility presents a serious health risk, at which point selling from that facility in the U.S. becomes a prohibited act.

Many Asian brands assume their importer handles all of this. Often, neither side has confirmed who actually owns each obligation. Clarify this before inventory ships.

Food: FSMA and the Foreign Supplier Verification Program

For Korean and Japanese snacks, condiments, and packaged food, the relevant law is the FDA Food Safety Modernization Act (FSMA) and specifically the Foreign Supplier Verification Program (FSVP). A U.S. importer of record is required to verify that foreign food suppliers are producing products in a manner that provides the same level of public health protection as the FSMA preventive controls rules. That verification must be documented. The FDA registers foreign food facilities, and unregistered facilities cannot legally export food to the U.S.

Allergens: sesame is now the ninth major allergen

The FASTER Act of 2021 added sesame as the ninth major food allergen in the U.S., effective January 1, 2023. Sesame is pervasive in Asian food products, often listed as “spice,” “natural flavor,” “goma,” or “sesame oil” in ways that do not meet U.S. labeling requirements. From 2023 forward, any product introduced into U.S. interstate commerce must clearly declare sesame in the ingredient list or in a “Contains: Sesame” statement. Under-labeled sesame is one of the most common and most avoidable compliance failures for Asian food brands entering the U.S.

2. The split funnel: discovery and purchase live on different platforms

In Korea, China, and Japan, discovery and checkout frequently collapse into a single moment. A Douyin viewer watches a host demonstrate a product and buys without leaving the app. A Korean shopper finds something through a Naver blog or Olive Young search and completes the purchase inside the same connected ecosystem. The path from interest to transaction is short and self-contained.

The U.S. funnel is structured differently. An American consumer typically discovers a product on TikTok, Instagram Reels, or YouTube, then searches for it before buying. That search almost always ends on Amazon, where review count, price, and Prime delivery make the final call. TikTok Shop, which expanded broadly in the U.S. in late 2023, has begun to close the gap for impulse-friendly SKUs, but for most categories, demand creation and conversion still happen on two different platforms.

The practical consequence is that you cannot run only one channel and expect the funnel to work. Social creates intent; Amazon captures it. If your Amazon listing is thin or unreviewed when a TikTok video generates curiosity, the traffic evaporates. If your social presence is weak, your Amazon listing sits invisible because no one arrives with prior brand awareness. Both sides of the funnel must be ready before you put serious money into either.

3. Trust infrastructure: review culture and the micro-creator ecosystem

Trust signals work differently in the U.S. than in most of Asia. In China, trust flows through livestream hosts and KOLs whose personal brand carries the weight of the recommendation. In Korea, celebrity and idol endorsements plus detailed, ingredient-led beauty education from niche creators together move product. These systems depend on a relatively small number of high-authority voices.

The U.S. runs on a distributed system. Brands build creator-affiliate ecosystems: dozens or hundreds of micro-creators, each with a storefront link or affiliate code, producing short-form content that feeds TikTok Shop, Amazon, and DTC funnels simultaneously. The Amazon Influencer Program allows creators with even modest followings to post product review videos that appear directly on product detail pages and earn commissions on purchases. Above that layer sits the review moat: a product with 400 credible reviews on Amazon converts; a product with eight does not, regardless of how much you spend on ads.

Third-party validation also carries more weight in the U.S. than most Asian brands expect. A dermatologist mention, a “bestseller at Sephora” badge, or a nutritionist’s note in a recipe video does more for an American shopper’s confidence than a single celebrity face. That kind of validation takes time and seeding to build, but it compounds. A brand with 500 Amazon reviews and coverage from 50 micro-creators is nearly impossible for a newcomer to displace.

4. Claims and localization failures: whitening, OTC drug traps, and more

Marketing language that is completely standard in Korea or Japan can create a regulatory problem the moment it crosses into a U.S. distribution center. The following are the most common translation failures.

Whitening becomes brightening

The word “whitening” is a standard cosmetic category term in Korean and Japanese beauty. In the U.S., it carries cultural sensitivity and, more importantly, legal risk. Claims that imply altering melanin production, treating hyperpigmentation, or correcting dark spots push a product toward drug territory under FDA’s “intended use” analysis. The safe replacement for U.S. copy is appearance-focused language: “brightens the look of skin,” “visibly evens skin tone,” “reduces the appearance of dark spots.” The distinction sounds minor. The regulatory consequence is not.

The cosmetic vs. OTC drug line

In the U.S., a product’s classification as a cosmetic or a drug is determined by its intended use, which the FDA infers primarily from marketing claims. “Anti-acne” claims convert a cleanser or toner into an OTC drug, which requires compliance with the FDA acne monograph, specific active ingredients within defined concentrations, a Drug Facts panel, and separate registration. Sunscreen is classified as an OTC drug in the U.S. A moisturizer with SPF 30 is both a cosmetic and an OTC drug, with all the associated labeling and compliance requirements for both. Most Korean and Japanese cosmetic brands have never encountered this distinction at home, because the cosmetic vs. drug line in those markets is drawn differently.

Food health claims

Disease-reduction language (“lowers cholesterol,” “supports immune health,” “prevents diabetes”) is tightly restricted in the U.S. under FDA and FTC rules. Asian snack and beverage brands should reframe claims around flavor, experience, and origin, not health outcomes that require substantiation the brand may not have in a form that satisfies U.S. standards.

Sustainability claims

The FTC’s Green Guides cover terms like “recyclable,” “biodegradable,” “compostable,” and “clean.” These must be substantiated and qualified appropriately. Brands that carry over vague sustainability language from home-market packaging run real FTC risk.

5. Underestimating operations: logistics, 3PL, and time zones

This is the barrier that surprises brands the most, because it is invisible during planning. The marketing plan looks good on paper, the product is strong, the regulatory work is complete, and then the operational reality of running a consumer brand in the U.S. from Asia sets in.

Fulfillment speed and expectations

Amazon Prime has set a baseline expectation in the U.S. of two-day delivery for most categories. A brand fulfilling from a single West Coast warehouse (or worse, shipping parcels directly from Asia) will routinely deliver to Midwest and East Coast customers in five to ten business days. That gap drives low review scores, high return rates, and poor repeat purchase metrics. The operational fix is U.S.-based fulfillment, either Amazon FBA or a multi-node 3PL with coast-to-coast coverage.

3PL selection and retail compliance

Many Asian brands choose 3PL partners on price alone, without asking whether the 3PL understands retailer routing guides, EDI requirements, or the fragility of K-beauty glass packaging. Retailer chargebacks for OTIF (on-time in-full) failures, incorrect labeling, or pallet configuration errors are a real margin killer that does not appear in the initial cost model. A 3PL that handles Amazon and DTC well may not handle Target or Ulta routing correctly. Vet partners against the specific channels you plan to use.

Time zones and decision latency

Running U.S. operations from a Seoul or Tokyo HQ means a 13-to-17-hour time difference for most of the U.S. market. When a promotion goes wrong, an Amazon listing gets suppressed, or an influencer campaign picks up unexpected traction and inventory runs out, decisions need to happen in the next hour, not the next business morning in Asia. Many brands underinvest in U.S.-based operational authority until after their first major fumble. Hire or partner with someone in the U.S. who has a decision mandate before that happens.

6. Treating the U.S. as one market

The U.S. is a country with the geographic and demographic complexity of a continent. A strategy calibrated for Los Angeles or New York will underperform in Atlanta, Columbus, or Phoenix, not because the product is wrong but because the value proposition, the channel mix, and sometimes the flavor profile or product format are different.

Coastal consumers (New York metro, Los Angeles, Seattle, San Francisco) are earlier adopters of international brands, tend toward premium positioning, and are highly responsive to social-native campaigns and boutique retail. They are also expensive to acquire and quick to move on to the next brand. The Midwest and South represent a larger consumer base, respond more strongly to value, reliability, and community-oriented messaging, and shop more heavily through mass retail and regional chains. A K-snack that gets viral attention in LA may sit untouched on a shelf in Indianapolis if no localized education or sampling accompanies the distribution.

The sequencing recommendation that most U.S. expansion advisors give Asian brands: validate online first (Amazon plus DTC), where geography matters less, then use that data to identify which regional markets show real repeat-purchase behavior before committing to physical retail in those regions. This approach avoids signing distribution agreements with national retailers before the brand has proof that consumers outside the coasts will actually buy and repurchase.

7. Frequently asked questions

Q1. What is the single most common reason Korean and Japanese brands fail in the U.S.?

Assuming that what worked at home will work in the U.S. with minor translation. The funnel structure, trust signals, regulatory framework, and channel economics are all different enough that a U.S. strategy needs to be built from the U.S. consumer outward, not adapted from the home-market playbook. The brands that succeed here treat it as a new launch, not an extension.

Q2. Does MoCRA apply to Korean or Japanese cosmetic brands that export to the U.S.?

Yes. MoCRA applies to any cosmetic product distributed in the United States, regardless of where it was manufactured. Foreign manufacturers must register their facilities with the FDA, list their products, maintain safety substantiation, and name a U.S. responsible person whose contact information appears on U.S. labels. Enforcement of facility registration and product listing has been in effect since July 2024.

Q3. What makes “anti-acne” labeling a problem in the U.S. when it is a normal cosmetic category in Korea?

In the U.S., the FDA determines product classification by intended use as communicated through marketing claims. A claim like “treats acne,” “clears blemishes,” or “anti-acne” implies treatment of a condition, which pushes the product into OTC drug territory under U.S. law. As an OTC drug, the product needs a Drug Facts panel, an approved active ingredient at a monograph-compliant concentration, and separate regulatory compliance. This distinction does not exist in the same form under Korean cosmetics law, which is why many Korean brands are caught off guard when they enter the U.S.

Q4. Why is sesame labeling such a common issue for Asian food brands?

Sesame became the ninth major food allergen in the U.S. as of January 1, 2023, under the FASTER Act. Asian food products, including sauces, snacks, noodles, and baked goods, frequently contain sesame listed as “spice,” “natural flavors,” “goma,” or “sesame oil” in ways that do not meet the U.S. requirement to declare sesame by name. Any product entering U.S. commerce after that date must explicitly name sesame in the ingredient list or in a “Contains” statement. Under-labeling is a common customs and FDA compliance flag for Asian food importers.

Q5. How important are Amazon reviews, and how do Asian brands build them quickly?

Amazon reviews are effectively infrastructure in the U.S. market. A listing with fewer than 50 credible reviews converts poorly regardless of ad spend or influencer support. The fastest legitimate path to early reviews is a structured sampling and creator-gifting program: send product to micro-creators and verified purchase buyers before turning on paid campaigns. Amazon’s Vine program can supplement this for new listings. Starting ad spend before a review base exists is a common and expensive mistake.

Q6. How should a Korean or Japanese brand think about the U.S. as a geographic market?

As several distinct regional markets that require different channel strategies. Coastal consumers (LA, NYC, Seattle) are earlier adopters and respond to premium and trend-forward positioning. Midwest and Southern consumers tend to weight value, reliability, and practical benefits more heavily and shop through mass retail more than specialty or DTC. A sequenced approach works best: validate on Amazon and DTC first, where geography is largely neutral, then use repeat-purchase data to decide which regional markets warrant physical retail investment.

Q7. How long does a realistic U.S. launch take for a Korean consumer brand?

Regulatory groundwork (MoCRA registration, U.S. label revision, FSVP documentation for food brands) typically takes three to six months if started from scratch. Building a review base of 50 to 100 Amazon reviews takes another two to four months with an active seeding program. A brand that arrives in the U.S. market with clean compliance, a reviewed Amazon listing, and a roster of 20 to 40 micro-creators is in a structurally different position than one that goes straight from overseas production to paid ads. Count on nine to twelve months from commitment to a point where the funnel is genuinely working.

8. The bottom line

The barriers covered in this article are not exotic problems. They are the specific, practical gaps between how consumer markets work in Korea, Japan, and China and how they work in the United States. Regulatory compliance (MoCRA, FSMA/FSVP, FASTER Act allergens) is a gate to pass before scaling spend. The funnel requires both social and Amazon to be ready simultaneously. Trust is built through review volume and a distributed creator ecosystem, not a few large KOLs. Claims that are standard at home can reclassify your product as an OTC drug or invite FTC scrutiny. Logistics and operations are harder from Asia than the marketing plan suggests. And the U.S. is not a single consumer market: what wins in LA requires a different execution to win in Columbus or Charlotte.

Calywire is a U.S.-based marketing agency, founded in 2014, that helps Korean and Japanese consumer brands enter and scale in the United States. We work across Amazon, TikTok Shop, creator marketing, search, and content, and we have navigated MoCRA compliance, claims localization, and operational setup with brands across beauty, food, and lifestyle. If you are planning a U.S. launch or troubleshooting one that has stalled, we are happy to give you an honest read on what it will actually take.

Sources

• U.S. Food & Drug Administration: Modernization of Cosmetics Regulation Act of 2022 (MoCRA)
• U.S. Food & Drug Administration: FSMA Final Rule: Foreign Supplier Verification Programs (FSVP) for Importers of Food
• U.S. Food & Drug Administration: FASTER Act of 2021: Sesame as the Ninth Major Food Allergen
• U.S. Food & Drug Administration: Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)